XPH

Fund Description
The SPDR S&P Pharmaceuticals ETF seeks to replicate as closely as possible before expenses the total return performance of the S&P Pharmaceuticals Select Industry Index (ticker: SPSIPHTR).
Fund Profile
Fund Name SPDR S&P Pharmaceuticals ETF
Fund Exchange Ticker XPH
Fund Sponsor State Street (SPDR)
Fund ISIN US78464A7220
Net Expense Ratio 0.35 %
Fund Inception Date 19 June 2006
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name S&P Pharmaceuticals Index
Index Provider S&P DJ Indices
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 19 March 2019
Asset Under Management 249.40 Million (USD)
1 Month Total Return 1.60 %
Year To Date Return 15.70 %
1 Year Total Return -1.98 %
3 Year Annualized Total Return 3.50 %
NAV 42.2696
Share Outstanding 5,900,270
Top 10 Holdings (19 March 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
Elanco Animal Health Inc. ELAN EQUI 0.0484883200
MYLAN NV MYL EQUI 0.0467022900
Zoetis Inc. Class A ZTS EQUI 0.0464136800
ALLERGAN PLC AGN EQUI 0.0461285500
PERRIGO CO PLC PRGO EQUI 0.0459806900
PFIZER INC PFE EQUI 0.0449193200
MERCK & CO. INC. MRK EQUI 0.0445697100
JAZZ PHARMACEUTICALS PLC JAZZ EQUI 0.0444154000
JOHNSON & JOHNSON JNJ EQUI 0.0435411700
ELI LILLY & CO LLY EQUI 0.0433985100